Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 917-925

  Xu, Wenming ^a   Wu, Wen ^b   Chen, Jingfu ^c   Guo, Runmin ^c,d   Lin, Jiancong ^a   Liao, Xinxue ^a   Feng, Jianqiang ^d  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Extracellular signal regulated kinase 1 2; H9c2 cell; High glucose; Hydrogen sulfide; P38 mitogen activated protein kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; GLUCOSE; HYDROGEN SULFIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SODIUM HYDROGEN SULFIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL GROWTH; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; GLUCOSE INTAKE; HEART MUSCLE CELL; HYPERGLYCEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; APOPTOSIS; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; HUMANS; HYDROGEN SULFIDE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84883408278     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1462     Document Type: Article

References (52)

1. Grundy SM, Benjamin IJ, Burke GL, et al: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100: 1134-1146, 1999.
2. Cai L and Kang YJ: Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1: 181-193, 2001.
3. Francis GS: Diabetic cardiomyopathy: fact or fiction? Heart 85: 247-248, 2001
4. Rodrigues B, Cam MC and McNeill JH: Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180: 53-57, 1998.
5. Privratsky JR, Wold LE, Sowers JR, Quinn MT and Ren J: AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
6. Ren J and Davidoff AJ: Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272: H148-H158, 1997.
7. Rahimi R, Nikfar S, Larijani B and Abdollahi M: A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59: 365-373, 2005.
8. Cai H and Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
9. Peake BF, Nicholson CK, Lambert JP, et al: Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 304: H1215-H1224, 2013.
10. Soetikno V, Sari FR, Sukumaran V, et al: Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Eur J Pharm Sci 47: 604-614, 2012.
11. Evans JL, Goldfine ID, Maddux BA and Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
12. Igarashi M, Wakasaki H, Takahara N, et al: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103: 185-195, 1999.
13. Yan J, Young ME, Cui L, Lopaschuk GD, Liao R and Tian R: Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119: 2818-2828, 2009.
14. Fang S, Jin Y, Zheng H, et al: High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway. Mol Cell Biochem 347: 175-182, 2011.
15. ?owicka E and Be-towski J: Hydrogen sulfide (H2S) ? the third gas of interest for pharmacologists. Pharmacol Rep 59: 4-24, 2007.
16. Moore PK, Bhatia M and Moochhala S: Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 24: 609-611, 2003
17. Geng B, Chang L, Pan C, et al: Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318: 756-763, 2004.
18. Calvert JW, Jha S, Gundewar S, et al: Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374, 2009.
19. Chen SL, Yang CT, Yang ZL, et al: Hydrogen sulphide protects H9c2 cells against chemical hypoxia-induced injury. Clin Exp Pharmacol Physiol 37: 316-321, 2010.
20. Yang Z, Yang C, Xiao L, et al: Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes. Int J Mol Med 28: 397-403, 2011.
21. Nicholson CK and Calvert JW: Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 62: 289-297, 2010.
22. Lan A, Liao X, Mo L, et al: Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells. PLoS One 6: e25921, 2011.
23. Dong XB, Yang CT, Zheng DD, et al: Inhibition of ROS-activated ERK1/2 pathway contributes to the protection of H2S against chemical hypoxia-induced injury in H9c2 cells. Mol Cell Biochem 362: 149-157, 2012.
24. Suzuki K, Olah G, Modis K, et al: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA 108: 13829-13834, 2011
25. Malhotra A, Vashistha H, Yadav VS, et al: Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. Am J Physiol Heart Circ Physiol 296: H380-H388, 2009.
26. Yuan Z, Feng W, Hong J, Zheng Q, Shuai J and Ge Y: p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. Nitric Oxide 20: 9-15, 2009.
27. Wilmer WA, Dixon CL and Hebert C: Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 60: 858-871, 2001.
28. Sugden PH and Clerk A: 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83: 345-352, 1998.
29. Guo R, Lin J, Xu W, et al: Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Int J Mol Med 31: 644-650, 2013.
30. Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by Bcl?2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
31. Yue TL, Wang C, Gu JL, et al: Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86: 692-699, 2000.
32. Strohm C, Barancik T, Brühl ML, Kilian SA and Schaper W: Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 36: 218-229, 2000.
33. Buehler A, Martire A, Strohm C, et al: Angiogenesis-independent cardioprotection in FGF?1 transgenic mice. Cardiovasc Res 55: 768-777, 2002.
34. Chen L, Liu L, Yin J, Luo Y and Huang S: Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol 41: 1284-1295, 2009.
35. Jain SK, Bull R, Rains JL, et al: Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12: 1333-1337, 2010.
36. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M and Moore PK: Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 333: 1146-1152, 2005.
37. Ahmad FU, Sattar MA, Rathore HA, et al: Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail 34: 203-210, 2012.
38. Whiteman M, Gooding KM, Whatmore JL, et al: Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 53: 1722-1726, 2010.
39. Gao Y, Yao X, Zhang Y, et al: The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol 152: 177-183, 2011.
40. Hu LF, Wong PT, Moore PK and Bian JS: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100: 1121-1128, 2007.
41. Hu LF, Lu M, Wu ZY, Wong PT and Bian JS: Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 75: 27-34, 2009.
42. Adhikari S and Bhatia M: H2S-induced pancreatic acinar cell apoptosis is mediated via JNK and p38 MAP kinase. J Cell Mol Med 12: 1374-1383, 2008.
43. Zhi L, Ang AD, Zhang H, Moore PK and Bhatia M: Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kappaB pathway. J Leukoc Biol 81: 1322-1332, 2007.
44. Mukherjee S, Lekli I, Goswami S and Das DK: Freshly crushed garlic is a superior cardioprotective agent than processed garlic. J Agric Food Chem 57: 7137-7144, 2009.
45. Hu Y, Chen X, Pan TT, et al: Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 455: 607-616, 2008.
46. Yang G, Wu L, Bryan S, Khaper N, Mani S and Wang R: Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res 86: 487-495, 2010.
47. Yang G, Yang W, Wu L and Wang R: H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem 282: 16567-16576, 2007.
48. Lu M, Hu LF, Hu G and Bian JS: Hydrogen sulfide protects astrocytes against H(2)O(2)?induced neural injury via enhancing glutamate uptake. Free Radic Biol Med 45: 1705-1713, 2008.
49. Kloesch B, Liszt M and Broell J: H2S transiently blocks IL?6 expression in rheumatoid arthritic fibroblast-like synoviocytes and deactivates p44/42 mitogen-activated protein kinase. Cell Biol Int 34: 477-484, 2010.
50. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T and Zhu YC: The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007.
51. Bliksøen M, Kaljusto ML, Vaage J and Stensløkken KO: Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg 34: 344-349, 2008.
52. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.